Siogen, Veeda Partner To Develop Doxorubicin
Doxorubicin is a drug which is used in chemotherapy for the treatment of leukemias, lymphomas and other cancers. Encapsulation of Doxorubicin in Siosomes is designed to increase efficacy
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
The licensing agreement between Spring Creek Capital and McCoy Enterprise, LLC/Vectoris Pharma, gives Spring Creek the exclusive rights to produce, market, distribute and sell products based on method
Singapore’s integrated research network offers multidisciplinary capabilities across basic and translational research. Biopolis is a biomedical research hub in Singapore that co-locates public-sector institutes and private-sector corporate labs.
The partnership will provide a synergy of combined solutions that will enable enhanced information exchange capabilities to increase the efficacy of the Regional Health Information Organization (RHIO) Financial